QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
QQQ   438.07 (+2.93%)
AAPL   184.37 (+1.12%)
MSFT   411.65 (+2.35%)
META   486.13 (+3.87%)
GOOGL   144.09 (+1.08%)
AMZN   174.58 (+3.55%)
TSLA   197.41 (+1.36%)
NVDA   785.38 (+16.40%)
NIO   5.85 (-2.01%)
AMD   181.86 (+10.69%)
BABA   76.12 (+0.70%)
T   16.59 (-2.41%)
F   12.12 (-0.16%)
MU   85.91 (+5.42%)
CGC   3.37 (-2.03%)
GE   151.67 (+1.74%)
DIS   107.63 (-0.04%)
AMC   4.42 (-3.28%)
PFE   27.55 (-0.43%)
PYPL   58.35 (+1.51%)
XOM   104.76 (-0.09%)
OTCMKTS:HAVLF

HAVN Life Sciences (HAVLF) Stock Price, News & Analysis

$0.0057
0.00 (0.00%)
(As of 02/22/2024 ET)
Today's Range
$0.0057
$0.0057
50-Day Range
$0.01
$0.06
52-Week Range
$0.01
$0.15
Volume
24 shs
Average Volume
7,423 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

HAVLF stock logo

About HAVN Life Sciences Stock (OTCMKTS:HAVLF)

HAVN Life Sciences Inc., a biotechnology company, engages in the research and development of psychopharmacological products from plants and fungi. The Company also focuses on developing methodologies for the standardize and quality-controlled extraction of psychoactive compounds from plants and fungi, including Psilocybe spp. mushrooms; and the genera directive compounds, such as psilocybin, psilocin, and baeocystin, as well as the development of natural health care products from non-regulated compounds. The company was incorporated in 2020 and is headquartered in Richmond, Canada.

HAVLF Stock Price History

HAVLF Stock News Headlines

Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
HAVN.CN - HAVN Life Sciences Inc.
HAVN Life Sciences Inc (HAVN)
AI Stock Caught Trading Under Secret Name
We have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion.  The company holds over 29,000 patents in the U.S. It pays an enormous dividend.
HAVN Life Provides Corporate Update
HAVN Life Sciences Inc. (HAVLF)
IIROC Trading Halt - HAVN
IIROC Trade Resumption - HAVN
HAVN Life enters supply agreement with MPB Group
HAVN Life Launches the Brain Evolve Series
See More Headlines
Receive HAVLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HAVN Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
2/22/2024
Next Earnings (Estimated)
4/08/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:HAVLF
CIK
N/A
Phone
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Key Executives

  • Mr. Tim Moore (Age 65)
    Interim CFO, CEO & Chairman
    Comp: $129.09k
  • Ms. Jenna Pozar
    Chief Operations Officer
  • Mr. Paul More
    Controller














HAVLF Stock Analysis - Frequently Asked Questions

How have HAVLF shares performed in 2024?

HAVN Life Sciences' stock was trading at $0.06 on January 1st, 2024. Since then, HAVLF shares have decreased by 90.5% and is now trading at $0.0057.
View the best growth stocks for 2024 here
.

Are investors shorting HAVN Life Sciences?

HAVN Life Sciences saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 20,900 shares, an increase of 422.5% from the December 31st total of 4,000 shares. Based on an average daily trading volume, of 1,600 shares, the short-interest ratio is currently 13.1 days.
View HAVN Life Sciences' Short Interest
.

When is HAVN Life Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 8th 2024.
View our HAVLF earnings forecast
.

When did HAVN Life Sciences' stock split?

HAVN Life Sciences shares reverse split on Wednesday, August 3rd 2022. The 1-30 reverse split was announced on Wednesday, August 3rd 2022. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, August 3rd 2022. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

How do I buy shares of HAVN Life Sciences?

Shares of HAVLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:HAVLF) was last updated on 2/22/2024 by MarketBeat.com Staff